首页> 外文OA文献 >ANGIOTENSIN CONVERTING ENZYME INHIBITORS AND ANGIOTENSIN RECEPTOR BLOCKERS: IS THERE A REASON TO CONSIDER AN EQUIVALENCE OF TWO DRUG CLASSES FROM THE EVIDENCE BASED MEDICINE STANDPOINT

【2h】

ANGIOTENSIN CONVERTING ENZYME INHIBITORS AND ANGIOTENSIN RECEPTOR BLOCKERS: IS THERE A REASON TO CONSIDER AN EQUIVALENCE OF TWO DRUG CLASSES FROM THE EVIDENCE BASED MEDICINE STANDPOINT

机译：血管紧张素转化酶抑制剂和血管紧张素受体阻滞剂：是否有理由考虑两种药物课程的当前药物的观点

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
S. Yu. Martsevich;
展开▼
作者单位

展开▼
年度 2013
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. ANGIOTENSIN CONVERTING ENZYME INHIBITORS AND ANGIOTENSIN RECEPTOR BLOCKERS: IS THERE A REASON TO CONSIDER AN EQUIVALENCE OF TWO DRUG CLASSES FROM THE EVIDENCE BASED MEDICINE STANDPOINT [J] . S. Yu. Martsevich Racional?naa Farmakoterapia v Kardiologii . 2013,第4期

机译：血管紧张素转换酶抑制剂和血管紧张素受体阻滞剂：从基于证据的药物标准中考虑两种药物的等效性是有原因的
2. Beta-blocker, angiotensin-converting enzyme inhibitor/angiotensin receptor blocker, nitrate-hydralazine, diuretics, aldosterone antagonist, ivabradine, devices and digoxin (BANDAID(2)): an evidence-based mnemonic for the treatment of systolic heart failure [J] . Chia N., Fulcher J., Keech A. Internal medicine journal . 2016,第6期

机译：β-受体阻滞剂，血管紧张素转换酶抑制剂/血管紧张素受体阻滞剂，硝酸盐-肼屈嗪，利尿剂，醛固酮拮抗剂，伊伐布雷定，装置和地高辛（BANDAID（2））：一种基于证据的助记符，用于治疗收缩性心力衰竭
3. Safety and tolerability of angiotensin-converting enzyme inhibitor versus the combination of angiotensin-converting enzyme inhibitor and angiotensin receptor blocker in patients with left ventricular dysfunction: a systematic review and meta-analysis of randomized controlled trials. [J] . Lakhdar R, Al-Mallah MH, Lanfear DE Journal of cardiac failure . 2008,第3期

机译：血管紧张素转换酶抑制剂与血管紧张素转换酶抑制剂和血管紧张素受体阻滞剂联合使用在左心功能不全患者中的安全性和耐受性：一项随机对照试验的系统评价和荟萃分析。
4. The Prevalence of Potential Clinically Significant Drug Interactions with Angiotensin-Converting Enzyme Inhibitors in Slovenia [C] . Marjetka P., Brane L, Polonca F. European Congress of Pharmacology . 2012

机译：斯洛文尼亚血管紧张素转化酶抑制剂潜在临床显着的药物相互作用的患病率
5. Comparison of monotherapy with angiotensin-converting enzyme inhibitors or angiotensin receptor blockers in improving health outcomes among veteran patients with type 2 diabetes. [D] . Campbell, Heather M. 2011

机译：与血管紧张素转换酶抑制剂或血管紧张素受体阻滞剂单一疗法改善2型糖尿病退伍军人患者健康结局的比较。
6. Effects of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers on Angiotensin-Converting Enzyme 2 Levels: A Comprehensive Analysis Based on Animal Studies [O] . Gábor Kriszta, Zsófia Kriszta, Szilárd Váncsa, 2021

机译：血管紧张素转换酶抑制剂和血管紧张素受体阻滞剂对血管紧张素转化酶2水平的影响：基于动物研究的综合分析
7. Effects of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers on Angiotensin-Converting Enzyme 2 Levels: A Comprehensive Analysis Based on Animal Studies [O] . Gábor Kriszta, Zsófia Kriszta, Szilárd Váncsa, 2021

机译：血管紧张素转换酶抑制剂和血管紧张素受体阻滞剂对血管紧张素转化酶2水平的影响：基于动物研究的综合分析

ANGIOTENSIN CONVERTING ENZYME INHIBITORS AND ANGIOTENSIN RECEPTOR BLOCKERS: IS THERE A REASON TO CONSIDER AN EQUIVALENCE OF TWO DRUG CLASSES FROM THE EVIDENCE BASED MEDICINE STANDPOINT

著录项

引文网络

相似文献

相关主题

期刊订阅